A range of other assessments besides the bladder pressure test work just as well in guiding treatment of female incontinence, researchers reported Saturday in The Lancet. Adobe stock/HealthDay A small ...
A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
Patients with urinary incontinence, sudden and overwhelming urges to urinate, frequent urination and similar problems are usually given the traditional urodynamic test to measure how well the bladder ...
Bright Uro Inc. this month received Food and Drug Administration approval for its first product, the Glean Urodynamics System. It’s the biggest milestone to date for the Irvine medical device maker ...
March 10 (UPI) --Identifying genetic mutations in urine could help detect bladder cancer years before symptoms arise, a new study presented Friday at the European Association of Urology annual ...
A simple and cost-effective urine test could improve early detection and management of bladder cancer, according to a brief issued by the International Agency for Research on Cancer (IARC). This test ...
A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer. A urine-based test may decrease the number of invasive cystoscopies in ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) announced today the publication of new data demonstrating that the company’s Decipher Bladder genomic classifier accurately ...
A small urine leak might prompt a woman to worry she'll need an uncomfortable and invasive bladder test to treat her incontinence. But good news -- such bladder pressure tests probably aren't ...
NEW YORK (Reuters Health) - In a new study, up to half - or more - of older adults on Medicare who had a heart, lung, stomach or bladder test had the same procedure repeated within three years. Those ...
Cellens, a Boston, MA-based cancer diagnostics startup, has raised a $6.5 million seed round. The company is developing a mechanobiology and AI-driven platform, BioFeel, for non-invasive cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback